Controlspan / Field notes   Enterprise GRC intelligenceResearch edition · October 2026 · US market
Comparisons / RESEARCH NOTE 07

Which approach fits US banks, healthcare organisations and public companies?

CONTROLSPAN RESEARCH DESKSECTION 03 · PAGE 7 OF 16Last updated 28 October 2026

Sector requirements should change the demonstration—not merely the supplier’s presentation deck. Use legal and regulatory specialists to confirm applicability. The tests below are procurement recommendations, not legal opinions.

Buyer segment Primary-source basis Comparison implication Recommended scenario
Banks and lenders The banking agencies’ third-party guidance covers planning, due diligence and selection, contract negotiation, monitoring and termination. (occ.gov) Compare the full vendor-risk lifecycle, not only questionnaire scoring A critical supplier changes service scope, develops a material issue and must be exited
Healthcare providers and health plans HHS guidance addresses risks to all e-PHI created, received, maintained or transmitted and says the Security Rule does not prescribe one risk-analysis methodology. (hhs.gov) Test scoping and risk-analysis completeness rather than accepting a framework checklist A clinical service, its technology and an external supplier share a dependency requiring remediation
Public companies and SOX programmes PCAOB AS 2201 distinguishes design effectiveness, operating effectiveness and the evidence necessary to support conclusions. (pcaobus.org) Evaluate test design, evidence, review and deficiency handling separately Evidence is collected successfully but does not demonstrate the control operated as intended
Internal-audit-led programmes The IIA’s Standard 7.1 addresses organisational independence and safeguards against impairment. (theiia.org) Shared data must not erase independent judgement or appropriate reporting relationships Management challenges a finding but cannot overwrite the audit conclusion

For mid-sized banks, include a sector-oriented comparator where its scope matches the need. Ncontracts publishes banking-specific enterprise risk, vendor management, compliance and findings-management offerings. Its existence is a reason to test a financial-services operating model against a broader suite—not evidence that it is best for every bank. (ncontracts.com)

For healthcare, Censinet describes healthcare-focused third-party risk, enterprise risk, operational dependencies and AI governance. Include it where those workflows matter, while separately testing whether it covers the full intended programme. (censinet.com)

Can shared controls preserve audit independence?

Our recommendation is to share suitable source records while separating ownership of assessments and conclusions. Organisational independence is a professional-governance requirement, not something a role-based access setting alone can establish. The IIA requires attention to reporting relationships and safeguards where responsibilities might impair independence. (theiia.org)

In the platform, test whether:

  • Management can maintain its control description without rewriting a completed audit assessment.
  • Auditors can retain an independent test result against the same control.
  • Evidence reuse preserves the scope, period, version and reviewing party.
  • Reopening a finding leaves its prior state and approvals traceable.
  • Sensitive investigations remain restricted even when aggregate reporting is shared.

Sources cited on this page

  1. occ.gov ↗www.occ.gov
  2. hhs.gov ↗www.hhs.gov
  3. pcaobus.org ↗pcaobus.org
  4. theiia.org ↗www.theiia.org
  5. ncontracts.com ↗www.ncontracts.com
  6. censinet.com ↗censinet.com
← PREVIOUS PAGEWhich other provider types deserve a place on the shortlist?NEXT →How should buyers compare integrations and continuous evidence?

Find the evidence.

Search across 188 research pages and 12 sections.